Enovis Completes Acquisition of LimaCorporate S.p.A
January 03, 2024 06:00 ET
|
Enovis Corporation
WILMINGTON, Del., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) an innovation-driven, medical technology growth company, today announced that it...
Enovis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 28, 2023 05:00 ET
|
Enovis Corporation
Wilmington, DE, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with...
Enovis Announces Business Segment Leadership Transition Plan
December 05, 2023 06:00 ET
|
Enovis Corporation
Brady R. Shirley, current President and COO, to retire effective April 1, 2025.Louie Vogt to be promoted to Group President of Reconstructive segment.Terry Ross to be promoted to Group President of...
Enovis to participate in the 6th Annual EverCore ISI HealthCONx Conference
November 16, 2023 16:15 ET
|
Enovis Corporation
Wilmington, DE, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will participate in the 6th Annual...
Enovis Announces Third Quarter 2023 Results and Raises Full-Year Outlook
November 07, 2023 06:00 ET
|
Enovis Corporation
Continued strong momentum with third quarter sales growth of 9% and strong adjusted EBITDA margin expansionOrganic growth of 10% in Recon and 4% in P&RReported a third quarter net loss...
Enovis™ to Showcase New Surgical Innovations at AAHKS Annual Meeting
October 30, 2023 08:00 ET
|
Enovis Corporation
Wilmington, DE, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Today, Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, announced it will showcase the latest technologies from...
ENOVIS CORPORATION ANNOUNCES PRICING OF PRIVATE OFFERING OF $400 MILLION OF 3.875% CONVERTIBLE SENIOR NOTES DUE 2028
October 20, 2023 06:00 ET
|
Enovis Corporation
Wilmington, DE, Oct. 20, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) today announced the pricing of $400 million aggregate principal amount of 3.875%...
Enovis Corporation Releases Preliminary Information About Its Performance for the Third Quarter 2023
October 19, 2023 06:58 ET
|
Enovis Corporation
Wilmington, DE, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) today released the following preliminary information about its performance for the third...
Enovis Corporation Announces Proposed Private Offering of $400 Million of Convertible Senior Notes
October 19, 2023 06:51 ET
|
Enovis Corporation
Wilmington, DE, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) today announced its intention to offer, subject to market conditions and other factors,...
Enovis to Host Third Quarter 2023 Results Conference Call on November 7th
October 16, 2023 07:00 ET
|
Enovis Corporation
Wilmington, DE, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will host an investor conference...